Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
Lauren Ramjee,1 Nesrin Vurgun,1 Christopher Ngai,2 Mit Patel,3 Gabriel Tremblay1 1Health Economics & Outcomes Research (HEOR), Cytel, Inc, Waltham, MA, USA; 2Market Access, Calliditas NA Enterprises, New York, NY, USA; 3Health Economics & Outcomes Research (HEOR), Calliditas NA Enterprises,...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Pukapuka |
| I whakaputaina: |
Dove Medical Press,
2023-03-01T00:00:00Z.
|
| Ngā marau: | |
| Urunga tuihono: | Connect to this object online. |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ipurangi
Connect to this object online.3rd Floor Main Library
| Tau karanga: |
A1234.567 |
|---|---|
| Tārua 1 | Wātea |